Oragenics, Inc.
OGEN · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,067 | -$2,272 | -$2,217 | -$3,349 |
| Dep. & Amort. | $0 | $0 | $193 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $7 | -$69 | $58 |
| Change in WC | -$1,136 | $372 | -$19 | $1,273 |
| Other Non-Cash | $1,218 | $579 | $0 | $0 |
| Operating Cash Flow | -$2,985 | -$1,314 | -$2,112 | -$2,018 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$133 | $2,033 | -$263 |
| Stock Issued | $0 | $0 | $2,635 | $2 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $12,415 | $0 | $0 | $0 |
| Financing Cash Flow | $12,415 | -$133 | $4,668 | -$261 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $9,430 | -$1,447 | $2,556 | -$2,279 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,974 | $3,421 | $865 | $3,144 |
| End Cash | $11,404 | $1,974 | $3,421 | $865 |
| Free Cash Flow | -$2,985 | -$1,314 | -$2,112 | -$2,018 |